Skip to main content
. Author manuscript; available in PMC: 2021 Feb 23.
Published in final edited form as: Urol Oncol. 2016 Aug 24;35(1):30.e1–30.e8. doi: 10.1016/j.urolonc.2016.07.013

Fig. 1.

Fig. 1.

A 53-year-old man with a serum PSA = 23.70 ng/ml. Axial T2W MRI (A) and ADC map of DW MRI (B) show a midline to the left peripheral zone lesion (arrows), which represents a Gleason 3 + 4 prostate cancer lesion detected on TRUS-guided systematic prostate biopsy. The lesion does not have an overt extension but has a TCL of 17.5 mm (= 1.75 cm) measured on axial T2W MRI (C). Whole-mount prostatectomy specimen with H&E staining shows Gleason 4 + 4 prostate cancer within the lesion and posterior extraprostatic extension (inked in black) (D).